Insights

Niche Innovation Mitotherapeutix specializes in RNA chemistry for developing targeted therapies against traditionally undruggable disease markers, indicating significant potential for partnerships with biotech firms seeking innovative drug development solutions.

Growing Revenue With estimated revenues between 1 million and 10 million dollars and a small team, the company presents an agile, emerging opportunity for service providers looking to support early-stage biotech startups.

Funding Opportunity The absence of publicly listed funding suggests potential opportunities for investment or strategic collaborations to support its research advancements and scale operations.

Tech Infrastructure Utilizing common web technologies and cloud hosting services, Mitotherapeutix maintains a modern digital presence, which can facilitate easy engagement and outreach for technology and research service providers.

Market Positioning In comparison to larger competitors like Alnylam Pharmaceuticals, Mitotherapeutix operates in a specialized niche within RNA therapeutics, making it a promising partner for innovative biotech and research service collaborations.

Mitotherapeutix Tech Stack

Mitotherapeutix uses 8 technology products and services including WordPress, oEmbed, imagesLoaded, and more. Explore Mitotherapeutix's tech stack below.

WordPress

Content Management System

oEmbed

Dev Tools

imagesLoaded

Javascript Libraries

jQuery Migrate

Javascript Libraries

Priority Hints

Performance

Hostgator

Web Hosting

Nginx

Web Servers

Apache

Web Servers

Mitotherapeutix Email Formats	Example	Percentage
FLast@mitotherapeutix.com	JDoe@mitotherapeutix.com	100%

Mitotherapeutix Email Formats

Example

Percentage

FLast@mitotherapeutix.com

JDoe@mitotherapeutix.com

100%

Frequently Asked Questions

Where is Mitotherapeutix's headquarters located?

Mitotherapeutix's main headquarters is located at 400 Farmington Avenue Farmington, Connecticut 06032 United States. The company has employees across 2 continents, including North AmericaEurope.

What is Mitotherapeutix's official website and social media links?

Mitotherapeutix's official website is mitotherapeutix.com and has social profiles on LinkedIn.

What is Mitotherapeutix's NAICS code?

Mitotherapeutix's NAICS code is 5417 - Scientific Research and Development Services.

How many employees does Mitotherapeutix have currently?

As of June 2026, Mitotherapeutix has approximately 6 employees across 2 continents, including North AmericaEurope. Key team members include Chief Executive Officer: J. T.Chief Scientific Officer: C. A.Chief Scientific Officer: T. M.. Explore Mitotherapeutix's employee directory with LeadIQ.

What industry does Mitotherapeutix belong to?

Mitotherapeutix operates in the Research Services industry.

What technology does Mitotherapeutix use?

Mitotherapeutix's tech stack includes WordPressoEmbedimagesLoadedjQuery MigratePriority HintsHostgatorNginxApache.

What is Mitotherapeutix's email format?

Mitotherapeutix's email format typically follows the pattern of FLast@mitotherapeutix.com. Find more Mitotherapeutix email formats with LeadIQ.

When was Mitotherapeutix founded?

Mitotherapeutix was founded in 2014.

Mitotherapeutix

Q: What is Mitotherapeutix's official website and social media links?

Mitotherapeutix's official website is mitotherapeutix.com. Mitotherapeutix has social profiles on LinkedIn.

Q: How many employees does Mitotherapeutix have currently?

Mitotherapeutix has approximately 6 employees.

Q: What technology does Mitotherapeutix use?

Mitotherapeutix's tech stack includes oEmbed, Jetpack, Priority Hints, Nginx, imagesLoaded.

Q: What is Mitotherapeutix's NAICS code?

Mitotherapeutix's NAICS code is 5417 (Scientific Research and Development Services).

Research ServicesConnecticut, United States2-10 Employees

Mitotherapeutix operates in the research services sector, concentrating on how RNA chemistry can inform the development of new therapeutics. The company focuses on siRNA-based approaches intended to address disease targets that are difficult to drug using traditional modalities.

Based in Farmington, Connecticut, it is a small organization, suggesting a specialized, early-stage focus within the RNA therapeutics space. The work positions Mitotherapeutix among entities supporting the discovery and development of RNA-based medicines, potentially serving research teams and pharmaceutical collaborators seeking to tackle undruggable targets.

Insights

Similar companies to Mitotherapeutix

Kodiak Sciences . Full-time

Stealth BioTherapeutics

Alnylam Pharmaceuticals

BioElectron Technology Corporation